The ETV6::NTRK3 fusion represents the canonical fusion (90% frequency) for both infantile fibrosarcoma and mammary analog secretory carcinoma, while being detected at a much lower frequency (5–10%) in a variety of other cancers of various lineages [17]. This evidence concerns the gene ETV6 and cancer.